1[1]Feldman EL,Stevebs MJ,Tnomas PK,et al.A practical two step quantitatire clinical and electrophysiological assess ment for the diagnosis and staging of diabetic neuropaty[J].Diabetic Care,1994,17:1281～1289
2[2]Valk GD,Grootenhuis PA,Van Eijk JT,et al.Methods for assessing diabetic polyneuropathy:validity and reproducibility of the measure ment of sensory symptom severity and nerve function tests[J].Diabetes Res Clin PRACT,2000,47(2):87～95
3[3]Nasseri K,Stijers RL,Dekhuijzen IS,et al.Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy[J].Electromygr Clin Neurophysiol,1998,38(5):295～299
4Hata T,Itoh E,Yoneda R. Mechanism of the analgesic effectof neurotropin[J].Japanese Journal of Pharmacology,1988,(02):165.
5Ruk M,Saleh S. Effects of neurotropin on hyperalgesia and all odynia inmononeuropathic rats[J].Life Sciences,1998,(10):1931.
6Kawamura M,Shinkwin M,Imai Y. Neurotropin induces antinociceptive effect by enhancing descending pain inhibitory systems involving 5-HT3 and Noradrenergic-2 receptors in spinal dorsal horn[J].Life Sciences,1998,(11):2181.
8Hotta N,Koh N,Sakakibara F. Neurotropin prevents neurophysioiogical abnormalities and ADP-induced hyperaggregability in rats with streptozotocin-induced diabetes[J].Life Sciences,1995,(11):2101.
9Haider A,Solish N. Focal hyperhidrosis:diagnosis and management [J]. CMAJ,2005,172(1) :69 -75.
